ProNAi Therapeutics (DNAI) Posts Wider-than-Expected Q3 Loss

ProNAi Therapeutics (NASDAQ: DNAI) reported Q3 EPS of ($11.03), $10.55 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M